Placebo for LAD603, LAD603
M-00223-20
Phase 2 small_molecule active
Quick answer
Placebo for LAD603, LAD603 for Alopecia areata is a Phase 2 program (small_molecule) at Almirall with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Almirall
- Indication
- Alopecia areata
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active